Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B‑8800 in lower-risk myelodysplastic syndrome

1. Foran,J.M.
2. Sanz,G.F.
3. Watts,J.M.
4. Brunner,A.M.
5. Fossard,G.
6. Della Porta,M.G.
7. Tsai,X.C.-H.
8. Garcia-Manero,G.
9. Dimicoli-Salazar,S.
10. Fletcher,L.
11. Kim,Y.J.
12. Font,P.
13. Alfonso-Piérola,A.
14. Alonso-Dominguez,J.M.
15. Benton,C.
16. Hong,J.
17. Malcovati,L.
18. Mazure,D.
19. Lee,J.-H.
20. Yeh,S.-P.
21. Goursaud,L.
22. Barcellini,W.
23. Wu,E.
24. Corzo,D.
25. Kuida,K.
26. Stone,R.M.
27. Show all authors +